Once Weekly Injection for Type 2 Diabetes

For adults with Type 2 Diabetes this clinical study may be of interest to you.

We are looking for adults 18 years of age or older who are diagnosed with Type 2 Diabetes.  The clinical study will evaluate the effectiveness of a once-weekly investigational combination product, IcoSema, in participants with type 2 diabetes inadequately controlled with daily basal insulin.

For more information, or to see if you qualify to participate in this study, call Metabolic Research Institute Inc. (561) 802-3060, ext. 8036 or visit: https://www.metabolic-institute.com/weekly-injection/